Treatment of osteosarcoma at first recurrence after contemporary therapy

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer

• Publication date

  2005-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cncr.21417PMID 16206297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High‐dose ifosfamide in relapsed pediatric osteosarcoma: Therapeutic effects and renal toxicity

  2005cited by this paper
• Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).

  2005cited by this paper
• Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

  2005cited by this paper
• Late relapse of osteosarcoma: Implications for follow‐up and screening

  2004cited by this paper
• Biology and therapeutic advances for pediatric osteosarcoma.

  2004cited by this paper
• The patterns of relapse in osteosarcoma: The memorial Sloan‐Kettering experience

  2004cited by this paper
• Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities.

  2003cited by this paper
• Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival.

  2003influential reference
• Radiotherapy for local control of osteosarcoma.

  2003cited by this paper
• Recurrences following primary osteosarcoma in adolescents and adults previously treated with chemotherapy.

  2003cited by this paper
• Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy

  2003cited by this paper
• Current Treatment of Osteosarcoma

  2001cited by this paper
• Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy.

  2001cited by this paper
• Definitive intraoperative very high-dose radiotherapy for localized osteosarcoma in the extremities.

  2001cited by this paper
• Long-term results after repeated surgical removal of pulmonary metastases.

  1998cited by this paper
• Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.

  1998cited by this paper
• Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.

  1997cited by this paper
• The role of chemotherapy in the management of non-metastatic operable extremity osteosarcoma.

  1997cited by this paper
• Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy.

  1997cited by this paper
• Osteosarcoma.

  1997cited by this paper
• Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival

  1995influential reference
• Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study.

  1991influential reference
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Targeting Methionine Addiction of Osteosarcoma with Methionine Restriction to Overcome Drug Resistance: A New Paradigm for a Recalcitrant Disease

  2025cites this paper
• Identification of EMT-related subtype and a 9 genes signature predicts the prognosis in osteosarcoma

  2025cites this paper
• Silent Persistence: Genomic Characterization of Late Pulmonary Relapse in Osteosarcoma After a Decade of Remission

  2025cites this paper
• Loss of Malignancy of Super-Methotrexate-resistant Osteosarcoma Cells Is Associated With an Increase of Methylated Histone Marks H3K9me3 and H3K27me3

  2024cites this paper
• Prolonged 14-day continuous infusion of high-dose ifosfamide for patients with relapsed and refractory high-grade osteosarcoma: a retrospective multicentre cohort study

  2024cites this paper
• Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma

  2024cites this paper
• Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression

  2024cites this paper
• Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation, treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study Group

  2023cites this paper
• Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study

  2023cites this paper
• The Role of FAS Receptor Methylation in Osteosarcoma Metastasis

  2023cites this paper
• Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy.

  2023cites this paper
• Boldine Treatment Induces Cytotoxicity in Human Colorectal Carcinoma and Osteosarcoma Cells

  2023cites this paper
• European standard clinical practice recommendations for children and adolescents with Primary and Recurrent osteosarcoma

  2023cites this paper
• High‐dose chemotherapy followed by autologous stem cell transplantation in pediatric patients with relapsed osteosarcoma

  2023cites this paper
• Controversies and Challenges in the Management of Osteosarcoma—an Indian Perspective

  2022cites this paper
• Peptide-based semiconducting polymer nanoparticles for osteosarcoma-targeted NIR-II fluorescence/NIR-I photoacoustic dual-model imaging and photothermal/photodynamic therapies

  2022cites this paper
• Identification of a novel glycolysis-related gene signature for predicting the prognosis of osteosarcoma patients

  2021cites this paper
• A protocol for systematic review and meta-analysis

  2021cites this paper
• Zoledronic Acid-Loaded β-TCP Inhibits Tumor Proliferation and Osteoclast Activation: Development of a Functional Bone Substitute for an Efficient Osteosarcoma Treatment

  2021cites this paper
• State-of-the-art, approved therapeutics for the pharmacological management of osteosarcoma

  2021cites this paper
• Clinical therapeutic effects of combined methotrexate and other chemotherapeutic agents in treating children and young patients with osteosarcoma

  2021cites this paper
• Resource‐appropriate selection of osteosarcoma treatment protocols in low‐ and middle‐income countries

  2021cites this paper
• High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series

  2020cites this paper
• Osteosarcoma: A comprehensive review of management and treatment strategies.

  2020cites this paper
• Alpha-Particle Therapy for Multifocal Osteosarcoma: A Hypothesis

  2020cites this paper
• Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma

  2020influential citation
• Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression

  2020cites this paper
• OTT_A_193363 5093..5112

  2020cites this paper
• Circulatory Biomarkers of Osteosarcoma: A Review

  2020cites this paper
• What is the best clinical approach to recurrent/refractory osteosarcoma?

  2020influential citation
• Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects

  2020cites this paper
• Comparison of MRI and Histopathology with regard to Intramedullary Extent of Disease in Bone Sarcomas

  2019cites this paper
• Cross-Species Gene Expression Analysis Reveals Gene Modules Implicated in Human Osteosarcoma

  2019cites this paper
• Use of three-dimensional printing and intraoperative navigation in the surgical resection of metastatic acetabular osteosarcoma

  2019cites this paper
• Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol

  2019cites this paper
• A risk score model for the prediction of osteosarcoma metastasis

  2019cites this paper
• The Team Approach to Osteosarcoma of the Distal Femur in an Adolescent

  2018cites this paper
• Postmetastasis survival in high‐grade extremity osteosarcoma: A retrospective analysis of prognostic factors in 126 patients

  2018cites this paper
• Identifying osteosarcoma metastasis associated genes by weighted gene co-expression network analysis (WGCNA)

  2018cites this paper
• Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group

  2018cites this paper
• Hesperidin exhibits in vitro and in vivo antitumor effects in human osteosarcoma MG-63 cells and xenograft mice models via inhibition of cell migration and invasion, cell cycle arrest and induction of mitochondrial-mediated apoptosis

  2018cites this paper
• Matrix metallopeptidase 9 targeted by hsa‐miR‐494 promotes silybin‐inhibited osteosarcoma

  2018cites this paper
• Considerations for Cancer-Directed Therapy in Advanced Childhood Cancer

  2018cites this paper
• Interested in publishing with us ? Contact book

  2018cites this paper
• Tumor Talk and Child Well-Being: Perceptions of "Good" and "Bad" News Among Parents of Children With Advanced Cancer.

  2017cites this paper
• Chapter 12 – Osteosarcoma Metastasis—Prognostic Factors and Treatment Strategies

  2017cites this paper
• Chemotherapy and Multidisciplinary Approaches to Pediatric Sarcomas

  2017cites this paper
• The long non-coding RNA PARTICLE is associated with WWOX and the absence of FRA16D breakage in osteosarcoma patients

  2017cites this paper
• Long non-coding RNAs in osteosarcoma

  2017cites this paper
• Team Approach: Osteosarcoma of the Distal Part of the Femur in Adolescents.

  2017cites this paper
• FH 535 suppresses the growth of osteosarcoma in vitro and vivo via downregulation Wnt / β-catenin signaling pathway

  2016cites this paper
• Follow-up practices for high-grade extremity Osteosarcoma

  2016cites this paper
• p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines

  2016cites this paper
• Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience

  2016cites this paper
• Osteosarcoma Overview

  2016cites this paper
• Time to relapse predicts post-relapse survival in recurrent osteosarcoma : a meta-analysis

  2016cites this paper
• Treatment of Osteosarcoma Patients with Pulmonary Metastasis

  2016cites this paper
• Dual Mechanism of Action of Resveratrol in Notch Signaling Pathway Activation in Osteosarcoma

  2016cites this paper
• MicroRNA-20b Downregulates HIF-1α and Inhibits the Proliferation and Invasion of Osteosarcoma Cells

  2016cites this paper
• Bryostatin I treatment induces apoptosis and enhances phosphorylation of p 65 NF-Kb in OHS-4 osteoblastic osteosarcoma cells

  2016cites this paper
• Oligo-Recurrence of Osteosarcoma Patients: Treatment Strategies for Pulmonary Metastases

  2015cites this paper
• Limb Salvage Strategy by Intra-Arterial Chemotherapy for LocalRecurrent Osteosarcoma in Extremities

  2015cites this paper
• Pirarubicin-based chemotherapy displayed better clinical outcomes and lower toxicity than did doxorubicin-based chemotherapy in the treatment of non-metastatic extremity osteosarcoma.

  2015cites this paper
• Récidives d’ostéosarcome et essais cliniques de phase II : quelles conclusions tirer de l’expérience passée ?

  2015cites this paper
• Molecular and Clinical Oncology

  2015cites this paper
• Fibroblast growth factor receptor 1 promotes MG63 cell proliferation and is associated with increased expression of cyclin-dependent kinase 1 in osteosarcoma

  2015cites this paper
• Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review

  2015cites this paper
• Recurrent Bone Tumors

  2015cites this paper
• Review of management issues in relapsed osteosarcoma

  2014cites this paper
• Tumor self-seeding by circulating tumor cells in nude mouse models of human osteosarcoma and a preliminary study of its mechanisms

  2014cites this paper
• What Are the Factors That Affect Survival and Relapse After Local Recurrence of Osteosarcoma?

  2014cites this paper
• Blocked Autophagy by miR-101 Enhances Osteosarcoma Cell Chemosensitivity In Vitro

  2014cites this paper
• Autophagy prevents doxorubicin‑induced apoptosis in osteosarcoma.

  2014cites this paper
• Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates

  2014cites this paper
• Evaluation of ifosfamide salvage therapy for metastatic canine osteosarcoma.

  2014cites this paper
• Mifamurtide in metastatic and recurrent osteosarcoma: A patient access study with pharmacokinetic, pharmacodynamic, and safety assessments

  2014cites this paper
• Molecular mechanisms of chemoresistance in osteosarcoma (Review)

  2014cites this paper
• Letter to the Editor: Surgical Resection of Relapse May Improve Postrelapse Survival of Patients with Localized Osteosarcoma

  2014cites this paper
• Rhabdomyosarcoma: current challenges and their implications for developing therapies.

  2014cites this paper
• Chemotherapy in Osteosarcoma

  2014cites this paper
• Innate immunity in osteosarcoma

  2014cites this paper
• Osteosarcoma with metastasis at initial diagnosis: Current outcomes and prognostic factors in the context of a comprehensive cancer center.

  2014cites this paper
• The Current and Future Therapies for Human Osteosarcoma.

  2013cites this paper
• Chemotherapy in pediatric bone and soft-tissue sarcomas

  2013cites this paper
• Metastatic and recurrent bone primary bone cancers.

  2013cites this paper
• Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway.

  2013cites this paper
• Potential application of titanium dioxide nanoparticles in the prevention of osteosarcoma and chondrosarcoma recurrence.

  2013cites this paper
• Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung

  2013cites this paper
• Retrospective analysis of prognostic factors for sixty osteosarcoma patients with local recurrence

  2013cites this paper
• Analysis of prognostic factors in 333 Chinese patients with high‐grade osteosarcoma treated by multidisciplinary combined therapy

  2013cites this paper
• Surgical Resection of Relapse May Improve Postrelapse Survival of Patients With Localized Osteosarcoma

  2013cites this paper
• Syngeneic Hematopoietic Stem Cell Transplantation Enhances the Antitumor Immunity of Intratumoral Type I Interferon Gene Transfer for Sarcoma

  2012cites this paper
• Pulmonary metastasectomy for bone and soft tissue sarcoma in Australia: 114 patients from 1978 to 2008

  2012cites this paper
• A role for maintenance therapy in managing sarcoma.

  2012cites this paper
• P‐glycoprotein binds to ezrin at amino acid residues 149–242 in the FERM domain and plays a key role in the multidrug resistance of human osteosarcoma

  2012cites this paper
• Pirarubicin inhibits multidrug-resistant osteosarcoma cell proliferation through induction of G2/M phase cell cycle arrest

  2012cites this paper
• Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.

  2011cites this paper
• Mifamurtide for the treatment of nonmetastatic osteosarcoma

  2011cites this paper
• Adjuvant Chemotherapy in Patients with Osteosarcoma

  2011cites this paper
• Unusual case of extrapulmonary metastatic recurrence in a patient with osteosarcoma.

  2011cites this paper